The role of T1 mapping and ECV over LGE in diagnosing HCM.

1 February 2018 (17:33 - 17:42)

Organised by:

About the speaker

Doctor Michael Salerno

Stanford University School of Medicine, Stanford (United States of America)

4 More presentations in this session

Presentation thumbnail

CMR as first line diagnostic test in children at risk for HCM?

Doctor M. Campbell (Liverpool, GB)

Presentation thumbnail

Athlete, hypertensive or hypertrophic heart?

Associate Professor V. Maestrini (Rome, IT)

Presentation thumbnail

Classic risk factors suffice in HCM patients to decide ICD therapy.

Associate Professor R. Kozor (St Leonards, AU)

Presentation thumbnail

Discussion.

Access the full session

Session thumbnail

Special Session 2 - Hypertrophic Heart: CMR for Diagnosis - Discuss with the Experts

The Event

CMR 2018 (the 5th joint EuroCMR/SCMR meeting)

1 February 2018 17:33 CET

You may be interested in

Congress Session

Advanced imaging in heart failure

Webinar

The role of cardiac magnetic resonance for patients with ventricular arrhythmias and the prevention of sudden cardiac death in light of the 2022 ESC Guidelines

Congress Session

How to do CMR - Part 2